We are pleased to share the permanent J-code for RYTELO™ (imetelstat). For infusion dates of service on or after January 1, 2025, J-code J0870 should be used for RYTELO claims.¹

Please consider updating your system to reflect the permanent J-code J0870 and units: 1 unit per 1 mg for use on or after January 1, 2025.

HCPCS Information:

RYTELO Package Information²

Wholesale Acquisition Cost (WAC) is the list price from a manufacturer to a wholesaler or a direct purchaser before any discounts or rebates are applied. The WAC price listed may differ significantly from actual prices paid by customers and consumers.

Click here to learn more about RYTELO.

It is always the provider’s responsibility to determine details specific to individual patients and to submit true and correct claims for the products and services rendered. Geron and its agents make no guarantee regarding reimbursement for any service or item. This information is not intended as reimbursement advice, legal advice, medical advice, or a substitute for a provider’s independent professional judgment.

Please see full Prescribing Information, including Medication Guide.

Reference: 1. Centers for Medicare & Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) application summaries and coding recommendations. Centers for Medicare & Medicaid Services. Updated October 7, 2024. Accessed October 8, 2024. https://www.cms.gov/files/document/2024-hcpcs-application-summary-quarter-3-2024-drugs-and-biologicals.pdf. 2. RYTELO. Prescribing Information. Geron Corp.; 2024

All Colorado prescribers and Connecticut prescribing practitioners and pharmacists click here for Wholesale Acquisition Cost for RYTELO.

Geron Corporation

919 E. Hillsdale Blvd., Suite 250

Foster City, CA 94404

This email advertisement is intended for U.S. healthcare providers only.

View the Geron Privacy Policy here.

©2024 Geron Corporation All rights reserved. C-US-RYT-IM-0199 11/24

GERON, GERON logo, RYTELO, and RYTELO logo are trademarks of Geron

Corporation.